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Pichinde virus (PV) strain AN 3739 was determined to be sensitive to natural killer (NK) cells in vivo by
enhanced replication in NK cell-depleted mice. An NK-sensitive subclone (PV-NKSl) was serially passed in mice
whose NK cells had previously been activated by an interferon inducer, and two plaque isolates were shown to
be resistant to NK cells but not to interferon. Inoculation of severe-combined-immunodeficient mice with
PV-NKSl led to a persistent infection resulting in an NK-resistant viral population. This is the first
demonstration of the isolation of viral "NK-escape" variants, as defined by the ability of the virus to replicate
in vivo.
Viruses evolve under the selective pressure of host de-
fense mechanisms, resulting in immunological escape vari-
ants or even in the formation of new viral species (6). The
antigenic drift of influenza viruses and changes in neutraliz-
ing antibody epitopes during persistent lentivirus infections
are examples of selection by antiviral antibodies (9, 13). A
cytotoxic T-cell-resistant variant of lymphocytic choriomen-
ingitis virus (LCMV) capable of escaping surveillance during
persistent infection has also been demonstrated (10). These
antibody- and cytotoxic-T-cell-escape variants arise from
mutations in their neutralization antibody-binding sites and
in immunodominant T-cell epitope sequence, respectively.
Natural killer (NK) cells play roles in the natural resis-
tance to a variety of viral infections, and their activities may
remain elevated for long periods of time during persistent
infections (2-3, 4, 15-17). The only persistent infection
adequately examined for the role of NK cells has been
persistent LCMV infection of mice. Depletion of the NK
cells in these persistently infected mice with antibodies did
not enhance LCMV synthesis, nor did it enhance LCMV
synthesis in acutely infected mice (1, 4). Thus, LCMV,
which normally causes persistent infection in mice under
conditions of elevated NK cell responses, appears to be an
NK-resistant virus.
While screening a variety of viruses for sensitivity to NK
cells in vivo, by using enhanced replication in NK cell-
depleted mice as an indicator of NK sensitivity, we found
that Pichinde virus (PV) fell into the category of being NK
sensitive (17). PV is an arenavirus distantly related to
LCMV, but, unlike LCMV, it does not normally establish
persistent infection in mice. We speculated that, given its
similarity to the NK-resistant LCMV, it might be possible to
select NK-resistant variants of PV by passage in mice in the
presence of NK cells. Here we report the generation of such
variants.
Isolation of NK-cell-resistant variants of PV. NK-resistant
variants of PV were established from an NK-sensitive
plaque-purified subclone (referred to henceforth as PV-
NKS1) of the AN 3739 strain of PV (17). C3H/HeSnJ mice
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(Jackson Laboratory, Bar Harbor, Maine), 4 to 8 weeks of
age, were inoculated intraperitoneally (i.p.) with 100 ,g of
the interferon (IFN)-inducing poly(I)-poly(C) (Sigma Chem-
ical Co., St. Louis, Mo.) in order to activate NK cells. Two
days later the mice were challenged with 2 x 106 PFU of
PV-NKsl diluted in Eagle's minimal essential medium sup-
plemented with antibiotics, glutamine, and 10% heat-inacti-
vated fetal bovine serum (MEM). After 3 days, the mice
were sacrificed, and spleen homogenates were prepared and
used to inoculate monolayers of L-929 cells. Isolated plaques
were collected and dispersed by sonic oscillation, and a virus
stock was grown in L-929 cells maintained in MEM. To
examine the sensitivity of the virus to NK cells in vivo,
groups of four to six C57BL/6 male mice which were 4 to 8
weeks old (Jackson Laboratory) were injected with 100 Rl of
a previously determined optimal dilution of an ascites prep-
aration of the immunoglobulin G 2a PK 136 monoclonal
antibody (MAb) to NK 1.1 (7) in MEM, in order to selec-
tively deplete NK-cell activity (17). Control mice received
100 RI of MEM instead of the MAb. Similar results were
obtained whether the MAb was administered i.p. or intrave-
nously. The mice were then inoculated i.p. with the virus.
Three days after inoculation of the virus, PFU titers in the
spleens of individual mice were examined by plaque assays
with Vero cells. NK cell activity was monitored by using
spleen cells from each individual mouse in a microcytotox-
icity assay with YAC-1 cells (14). Comparisons between
groups were done by using the Student t test.
The different in vivo-passaged, plaque-purified viruses
were examined for sensitivity to NK cells compared with
NK-sensitive PV-NKsl and then subjected to additional
passages in poly(I)-poly(C)-treated C3H/HeSnJ mice. Two
NK-resistant variants of PV (PV-NKrl and PV-NKr2) were
identified after 3 consecutive passages in vivo. Table 1
shows that splenocytes recovered from mice inoculated with
the NK-sensitive PV-NKsl and with either of the variants
mediated significant killing of YAC-1 cells. Cytotoxicity was
reduced by 80 to 100% by treatment of the mice with MAb to
NK 1.1. As shown in Table 2, PV-NKsl consistently repli-
cated to higher titers in the spleens of NK cell-depleted mice
than in control mice, as would be predicted for an NK-
sensitive virus. In contrast, plaque-purified PV-NKrl and
PV-NKr2 replicated to high titers in both groups of mice,
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TABLE 1. NK cell-mediated cytotoxicity in control virus-
infected mice and in mice depleted of NK cells by using anti-NK
1.1 MAba
Results for:
Virus Expt Controlb Mice given
mice anti-NK 1.1'
PV-NKsl 1 31 + 6.9 5.2 ± 3.3
2 32 1.9 1.8 ± 0.3
3 35 ± 2.5 2.3 ± 1.7
4 41 ± 5.0 5.4 ± 1.0
5 68 ± 9.1 9.1 ± 1.4
6 28 ± 2.9 2.9 ± 1.4
7 24 ± 15 -13 ± 0.8
PV-NKrl 1 26 ± 3.5 -0.2 ± 0.5
2 38 ± 4.3 1.7 ± 0.8
3 35 t 5.3 0.0 ± 0.9
4 45 t 4.0 5.2 ± 0.6
5 71 ± 7.9 6.8 ± 3.0
PV_NKr2 1 56 ± 3.1 0.8 ± 0.8
2 36 t 5.5 0.6 ± 0.7
3 56 t 6.6 5.0 + 2.4
PV.NKscid 1 39 ± 6.9 4.1 ± 1.0
2 35 ± 12.3 -12 ± 2.6
Results represent means of the percent specific cytotoxicity against
YAC-1 cells in 4-h microcytotoxicity assays ± standard deviations for four to
six mice tested separately, using effector/target ratios of 100:1.
b 100 p1l of MEM injected i.p. or intravenously.
I 100 .1 of MAb NK 1.1 injected i.p. or intravenously.
regardless of whether the NK cells had been eliminated by
treatment of the animals with MAb to NK 1.1. On the
average, an increase in the titers of PV-NKsl of 0.8 (6.3-fold)
+ 0.3 log1o PFU per spleen was found in the MAb anti-NK
1.1-treated mice. In contrast, depletion of NK cells resulted
in insignificant increases in the titers of both PV-NKr' and
PV-NKr2 (0.1 + 0.3 and 0.03 + 0.1 log10 PFU per spleen,
respectively). Note that the virus titers in mice inoculated
with the NK-resistant variants approached the virus titers
found in the anti-NK 1.1-treated mice inoculated with the
NK-sensitive PV variant. This is of significance, because a
20- to 40-fold-lower inoculum of the NK-resistant variants
was used (Table 1), further indicating that these viruses
replicate very efficiently in both NK cell-depleted and in
control mice. In addition, we have recently shown that
PV-NKrl replicates to similar titers in untreated or NK
cell-depleted mice with severe combined immunodeficiency
(SCID) (16). PV-NKsl, on the other hand, replicates to
significantly higher titers in NK cell-depleted SCID mice
(16).
Both the NK-sensitive PV-NKSl and the NK-resistant
variant PV-NKr' establish asymptomatic, persistent infec-
tion in SCID mice (16). We asked whether an NK-resistant
virus could be recovered from SCID mice persistently in-
fected with PV-NKVl. Homozygous SCID mice from the
BALB/c CB17 background, bred in microisolator cages in
the Department of Animal Medicine at the University of
Massachusetts Medical Center, were inoculated i.p. with 2
x 106 PFU of PV-NKsl in MEM. At 53 days postinfection
the mice were bled, and virus titers were determined in a
plaque assay with Vero cells. A virus stock was grown in
L-929 cells. The sensitivity to NK cells of this non-plaque-
purified virus isolate (PV-NKscid) was examined as de-
scribed above. Table 1 shows the results from two indepen-
dent experiments. PV-NKacid replicated to similar levels in
control C57BL/6 mice and in mice treated with MAb to NK
1.1. Note that in the latter group of mice, NK cell activity
was completely abrogated by the treatment with the MAb
(Table 1). The above results are a clear indication that
NK-resistant variants of an NK-sensitive virus may arise by
in vivo selection during persistent infection.
Sensitivity of the PV variants to NK cells in vitro. Although
we found that the PV variants were greatly divergent in their
sensitivities to NK cells in vivo, we were unable to consis-
tently and unequivocally demonstrate a difference in their
sensitivities to NK cells as assessed by in vitro microcyto-
toxicity assays with monolayers of L-929 cells incubated
with the different viruses for various periods of time and
exposed to either endogenous or activated NK cells (data
not shown). An analogous phenomenon has been found with
murine cytomegalovirus. Whereas this virus is extremely
sensitive to NK cells in vivo, murine cytomegalovirus-
infected cells appear to be less sensitive than uninfected cells
to lysis by activated NK cells in short in vitro cytotoxicity
assays (3).
IFN is capable of protecting target cells from NK cell-
mediated lysis, and we have reported that infection of
fibroblasts with the NK-sensitive murine cytomegalovirus
blocks the ability of IFN to protect targets from NK cells; in
contrast, the NK-resistant LCMV is a poor inhibitor of
IFN-mediated protection (3). We therefore tested whether
PV infection of L-929 cells inhibited IFN-mediated protec-
tion. Cells were infected with PV-NKsl or PV-NKrl at a
multiplicity of infection of about 0.1, incubated for 48 h, and
then exposed overnight to 10,000 U of beta IFN (IFN-p).
They then were exposed to PV-NKVl-induced C3H/HeSnJ
mouse NK cells. IFN nearly completely protected unin-
fected L-929 cells from NK cell-mediated lysis (33% for
TABLE 2. Replication of NK-sensitive and NK-resistant variants
of PV in control and NK cell-depleted mice'
Results for:
Virus Expt Control" Mice given P valued
mice anti-NK 1.1' au
PV-NKs1 1 <2.1 2.9 ± 0.5 <0.005
2 2.5 ± 0.5 3.1 ± 0.4 <0.05
3 3.4 ± 0.7 4.7 ± 0.2 <0.005
4 3.1 ± 0.4 3.6 ± 0.4 <0.05
5 3.7 ± 0.3 4.5 ± 0.2 <0.0025
6 3.5 ± 0.1 4.2 ± 0.0 <0.0005
7 3.5 ± 0.3 4.5 ± 0.2 <0.001
PV-NKrl 1 3.6 ± 0.6 3.6 ± 0.3 >0.9
2 3.6 ± 0.2 3.5 ± 0.8 <0.8
3 3.6 ± 0.5 4.0 ± 0.7 <0.25
4 3.8 ± 3.5 3.5 ± 0.3 <0.05
5 4.4 ± 0.4 4.9 ± 0.3 <0.1
PV_NKr2 1 3.3 ± 0.2 3.2 ± 0.7 <0.8
2 2.6 ± 0.5 <2.7 ± 0.7 <0.9
3 3.5 ± 0.3 3.4 ± 0.4 >0.9
PV-NKScid 1 5.0 ± 0.3 4.6 ± 0.4 <0.25
2 5.4 ± 0.7 5.5 ± 0.2 <0.9
a See Table 1, footnote a. Results were determined by the Student t test and
are given as log1o PFU per spleen.
b See Table 1, footnote b.
c See Table 1, footnote c.
d Inocula: PV-NKsl, 1 x 106 to 3 x 106 PFU per mouse; PV-NKTl and
PV-NKr2, 5 x 104 PFU per mouse; PV-NKsid, 1 x 106 PFU per mouse.
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TABLE 3. Sensitivity of PV variants to IFN





12 U 4.4 4.7
120U 4.1 4.0
1,200 U 3.3 2.6
IFN-1
12 U 5.3 5.3
120U 4.1 4.0
1,200 U 3.7 3.2
IFN--y
0.5 U 5.2 4.5
5U 5.0 5.0
50 U 4.3 3.5
IFN-13 (120 U) + IFN--y (5 U) 3.8 3.3
IFN-1, (1,200 U) + IFN--y (50 U) 3.0 2.8
control and 3.7% for IFN-treated mice; effector/target ratio
= 100:1) but protected virus-infected cells by only about
50% (with PV-NKS1, 53% for control and 26% for IFN-
treated mice; with PV-NKrl, 50% for control and 26% for
IFN-treated mice). Thus, even though PV infections caused
some impairment of the IFN-mediated protection, no differ-
ences in the degree of IFN-mediated protection were noted
between the NK-sensitive and NK-resistant variants on this
cell line.
Sensitivity of the PV variants to IFN. Because the selection
of the NK-resistant variants of PV was accomplished by
using conditions under which high levels of IFN were
generated, and because NK cells themselves are capable of
synthesizing IFN, we examined whether the PV variants
differed in the ability to replicate in vitro in the presence of
IFN. To this end, 5 x 105 L-929 cells in MEM were plated on
6-well plates (no. 3406; Costar, Cambridge, Mass.) and
incubated for 24 h with different amounts of mouse IFN-ao,
IFN-, (Lee Biomolecular, San Diego, Calif.), or IFN--y
(Amgen Biologicals, Thousand Oaks, Calif.). The cells were
then challenged with 105 PFU of PV variant PV-NKal or
PV-NKr1, and cell-free supematants were harvested 24 h
later. The virus titers in the supernatants were determined in
plaque assays with Vero cells. As shown in Table 3, which
shows representative results for a typical experiment, no
significant differences were found in the sensitivities of
either of the PV variants to IFN. Additional experiments
demonstrated that PV_NKscid and PV-NKal did not differ
significantly from each other in their sensitivities to IFN. We
also examined whether a difference existed in the levels of
interferon induced in mice inoculated with either of the PV
variants. After 3 days of infection, sera from individual
C57BL/6 or C3H/HeSnJ mice were tested for IFN by limit-
ing dilution on monolayers of L-929 cells in microtiter wells,
followed by challenge with vesicular stomatitis virus, as
described previously (1). Data are expressed as the recipro-
cal of the twofold dilution which showed a 50% inhibition in
cytopathic effect per milliliter of serum. As can-be seen from
Table 4, both PV-NKrl and PV-NKacid induced slightly
higher levels of IFN in both C57BL/6 and C3H/HeSnJ mice
than did PV-NKal. This latter observation, however, may
only be a reflection of the fact that, as discussed earlier, the
NK-resistant variants of PV appear to replicate much more
efficiently in vivo than the NK-sensitive variant of PV (Table
2). Nevertheless, taken together the above observations
suggest that the greater ability of the NK-resistant variants
of PV to replicate in vivo in normal mice is not due to an
increased resistance of the viruses to the growth-inhibitory
(antiviral) effects of IFN but rather to their increased resis-
tance to the control exerted by the NK cells
Discussion. Correlations between sensitivities to NK cells
in vitro and in vivo have been demonstrated with virus-
infected tumor cells. Adenovirus-transformed cells with
high-level sensitivity to NK cells grow poorly as tumors in
athymic nude mice (5). BHK cells persistently infected with
vesicular stomatitis virus grow poorly in nude mice, corre-
lating with high-level sensitivity to NK cells in vitro (8, 11,
12). When a vesicular stomatitis virus variant isolated from
resistant tumor cells was used to establish a new persistent
infection, these tumor cells remained resistant to NK cells in
vitro and in vivo.
Our study with PV is the first demonstration of NK-escape
variants of a virus-as defined by the ability of the virus to
replicate in vivo. Of note is that we did not observe a
correlation between NK sensitivity in vivo and sensitivity to
NK cell-mediated lysis in vitro. This is not surprising, as we
have not seen this correlation with other viruses, such as
with the highly NK-sensitive murine cytomegalovirus (3).
The sensitivity of virus-infected cells to NK cells in vivo is
likely to vary with the cell type infected and to be strongly
influenced by cytokines, such as IFN, which can modulate
the sensitivity of target cells to lysis (3). We also did not
observe a difference in the relative abilities of PV-NKW1 and
PV-NKrl to inhibit IFN-mediated protection of L-929 target
cells in vitro. These studies were, however, done with one
cell line, and it is possible that the natural targets of infection
in vivo would respond differently in terms of sensitivities to
cytokines and to NK cells.
These studies provide direct evidence that a dynamic
selection of viral variants which differ in their sensitivities to
NK cells occurs in vivo. An NK-resistant variant of a virus
should have a selective advantage under conditions of virus-
induced NK cell activation, which occurs at high levels in
acute infections (14). These studies also indicate that the
selective pressure of a continuous NK cell response during a
persistent infection may select for NK resistance, as has
apparently occurred in nature with LCMV. A molecular
analysis of these variants should help in determining the
molecular basis for NK sensitivity and resistance.
TABLE 4. Induction of IFN in vivo by variants of PV
Log2 of IFN/ml after induction by':
Expt Mouse strain
PV-NKS1 PV-NKr1 PV.NKSCid
1 CS7BL/6 8.3 8.8 10.3
C3H/HeSnJ 7.8 9.3 10.3
2 C57BL/6 10.0 11.8 11.8
3 C3H/HeSnJ 9.3 13.3 14.8
a Results are the mean IFN levels in sera from two animals tested
separately. Mice were inoculated with virus as described in Table 2, footnote
d.
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